Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma

Bone Marrow Transplantation, Published online: 15 February 2024; doi:10.1038/s41409-024-02233-2Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma

Source: Bone Marrow Transplantation - February 15, 2024 Category: Hematology Authors: Meera Mohan Aniko Szabo Anannya Patwari Jean Esselmann Tanvi Patel Ramya Bachu Lisa E. Rein Abhishek Janardan Vineel Bhatlapenumarthi Evanka Annyapu Catherine Skoog Areyl Goff Samer Al Hadidi Sabarinath Venniyil Radhakrishnan Sharmilan Thanendrarajan Maur Source Type: research